Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 54 | 2024 | 394 | 12.750 |
Why?
|
| Substance Abuse, Intravenous | 11 | 2023 | 27 | 3.760 |
Why?
|
| Anti-HIV Agents | 9 | 2023 | 55 | 3.070 |
Why?
|
| Substance-Related Disorders | 8 | 2024 | 127 | 2.400 |
Why?
|
| Alcoholism | 8 | 2024 | 101 | 2.330 |
Why?
|
| Alcohol Drinking | 8 | 2023 | 247 | 2.310 |
Why?
|
| Medication Adherence | 6 | 2021 | 161 | 1.840 |
Why?
|
| Anti-Retroviral Agents | 7 | 2021 | 21 | 1.700 |
Why?
|
| Malawi | 14 | 2023 | 19 | 1.560 |
Why?
|
| Sexual Behavior | 9 | 2021 | 107 | 1.550 |
Why?
|
| Acquired Immunodeficiency Syndrome | 4 | 2023 | 16 | 1.500 |
Why?
|
| Motivation | 4 | 2021 | 111 | 1.470 |
Why?
|
| Adult | 41 | 2024 | 9327 | 1.410 |
Why?
|
| Humans | 76 | 2024 | 31836 | 1.350 |
Why?
|
| Pharmaceutical Preparations | 4 | 2021 | 36 | 1.310 |
Why?
|
| Drug Users | 4 | 2023 | 10 | 1.210 |
Why?
|
| Female | 47 | 2024 | 19859 | 1.170 |
Why?
|
| Vietnam | 19 | 2023 | 24 | 1.150 |
Why?
|
| Mass Screening | 5 | 2024 | 263 | 1.140 |
Why?
|
| Young Adult | 17 | 2022 | 2603 | 1.070 |
Why?
|
| Disclosure | 3 | 2022 | 31 | 1.020 |
Why?
|
| Male | 42 | 2024 | 19091 | 1.020 |
Why?
|
| Condoms | 3 | 2021 | 34 | 1.000 |
Why?
|
| Needle-Exchange Programs | 3 | 2020 | 3 | 0.930 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2022 | 168 | 0.920 |
Why?
|
| Antiretroviral Therapy, Highly Active | 4 | 2018 | 29 | 0.900 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2020 | 32 | 0.880 |
Why?
|
| Cross-Sectional Studies | 13 | 2024 | 1527 | 0.850 |
Why?
|
| Contact Tracing | 2 | 2023 | 8 | 0.830 |
Why?
|
| Risk Reduction Behavior | 2 | 2020 | 125 | 0.820 |
Why?
|
| HIV Seropositivity | 2 | 2022 | 14 | 0.770 |
Why?
|
| Depressive Disorder, Major | 1 | 2021 | 42 | 0.760 |
Why?
|
| Depression | 11 | 2023 | 442 | 0.750 |
Why?
|
| Rural Population | 7 | 2023 | 273 | 0.750 |
Why?
|
| Syringes | 1 | 2020 | 5 | 0.730 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2021 | 43 | 0.730 |
Why?
|
| Sexual Partners | 8 | 2023 | 34 | 0.720 |
Why?
|
| Patient Preference | 1 | 2020 | 47 | 0.700 |
Why?
|
| Viral Load | 8 | 2023 | 70 | 0.700 |
Why?
|
| Choice Behavior | 1 | 2020 | 87 | 0.670 |
Why?
|
| Opioid-Related Disorders | 4 | 2020 | 54 | 0.640 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2015 | 32 | 0.640 |
Why?
|
| Cameroon | 3 | 2022 | 4 | 0.620 |
Why?
|
| Hepatitis C | 1 | 2018 | 41 | 0.600 |
Why?
|
| Adolescent | 11 | 2023 | 3511 | 0.600 |
Why?
|
| Marijuana Abuse | 1 | 2016 | 19 | 0.550 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2019 | 353 | 0.530 |
Why?
|
| Harm Reduction | 4 | 2019 | 14 | 0.510 |
Why?
|
| Counseling | 5 | 2024 | 97 | 0.500 |
Why?
|
| Continuity of Patient Care | 1 | 2016 | 69 | 0.500 |
Why?
|
| Pregnancy Outcome | 1 | 2015 | 90 | 0.500 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 240 | 0.490 |
Why?
|
| Virus Replication | 1 | 2013 | 42 | 0.450 |
Why?
|
| Health Services Accessibility | 3 | 2020 | 242 | 0.440 |
Why?
|
| Kentucky | 3 | 2022 | 15 | 0.440 |
Why?
|
| Urethritis | 2 | 2023 | 3 | 0.430 |
Why?
|
| Social Support | 4 | 2021 | 180 | 0.420 |
Why?
|
| HIV-1 | 2 | 2023 | 45 | 0.420 |
Why?
|
| Prevalence | 7 | 2024 | 979 | 0.410 |
Why?
|
| Ukraine | 6 | 2023 | 6 | 0.400 |
Why?
|
| Indonesia | 6 | 2023 | 8 | 0.400 |
Why?
|
| Ohio | 5 | 2022 | 58 | 0.390 |
Why?
|
| Qualitative Research | 3 | 2024 | 166 | 0.380 |
Why?
|
| Substance Abuse Treatment Centers | 2 | 2020 | 3 | 0.370 |
Why?
|
| Focus Groups | 2 | 2020 | 114 | 0.340 |
Why?
|
| Appalachian Region | 4 | 2021 | 17 | 0.320 |
Why?
|
| Unsafe Sex | 3 | 2017 | 23 | 0.320 |
Why?
|
| Analgesics, Opioid | 4 | 2022 | 231 | 0.280 |
Why?
|
| Interviews as Topic | 4 | 2020 | 262 | 0.270 |
Why?
|
| Middle Aged | 11 | 2024 | 11824 | 0.270 |
Why?
|
| Pregnancy | 6 | 2023 | 994 | 0.270 |
Why?
|
| Ambulatory Care Facilities | 3 | 2023 | 83 | 0.270 |
Why?
|
| Cohort Studies | 3 | 2023 | 1824 | 0.250 |
Why?
|
| Tuberculosis | 2 | 2023 | 14 | 0.250 |
Why?
|
| Treatment Outcome | 6 | 2020 | 3294 | 0.240 |
Why?
|
| Developing Countries | 1 | 2024 | 48 | 0.240 |
Why?
|
| Homosexuality, Female | 1 | 2023 | 1 | 0.230 |
Why?
|
| Child Abuse | 1 | 2024 | 27 | 0.230 |
Why?
|
| Mental Disorders | 1 | 2024 | 121 | 0.220 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2023 | 47 | 0.220 |
Why?
|
| Contraception | 1 | 2022 | 13 | 0.210 |
Why?
|
| Perception | 2 | 2020 | 98 | 0.200 |
Why?
|
| Peer Group | 1 | 2022 | 44 | 0.200 |
Why?
|
| Safe Sex | 2 | 2019 | 14 | 0.200 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2018 | 32 | 0.200 |
Why?
|
| Sex Offenses | 1 | 2021 | 2 | 0.200 |
Why?
|
| Crime Victims | 1 | 2021 | 9 | 0.200 |
Why?
|
| Psychotherapy, Brief | 1 | 2020 | 5 | 0.190 |
Why?
|
| Zimbabwe | 2 | 2022 | 22 | 0.190 |
Why?
|
| Africa South of the Sahara | 2 | 2019 | 21 | 0.180 |
Why?
|
| Influenza Vaccines | 1 | 2021 | 78 | 0.180 |
Why?
|
| Asthma | 1 | 2023 | 298 | 0.180 |
Why?
|
| Interinstitutional Relations | 1 | 2020 | 12 | 0.180 |
Why?
|
| Behavior, Addictive | 1 | 2020 | 32 | 0.180 |
Why?
|
| Emergency Medical Technicians | 1 | 2020 | 11 | 0.180 |
Why?
|
| Treponema pallidum | 1 | 2020 | 7 | 0.180 |
Why?
|
| Risk-Taking | 2 | 2017 | 93 | 0.180 |
Why?
|
| Intention | 1 | 2020 | 28 | 0.180 |
Why?
|
| Papillomaviridae | 1 | 2020 | 20 | 0.180 |
Why?
|
| Syphilis | 1 | 2020 | 10 | 0.180 |
Why?
|
| Influenza, Human | 1 | 2021 | 122 | 0.180 |
Why?
|
| Cooperative Behavior | 1 | 2020 | 81 | 0.170 |
Why?
|
| Sleep | 1 | 2020 | 92 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2020 | 504 | 0.170 |
Why?
|
| Clinical Clerkship | 1 | 2019 | 42 | 0.160 |
Why?
|
| Papillomavirus Infections | 1 | 2020 | 65 | 0.160 |
Why?
|
| Uganda | 2 | 2015 | 8 | 0.160 |
Why?
|
| Heterosexuality | 1 | 2018 | 13 | 0.160 |
Why?
|
| Suicide, Attempted | 1 | 2018 | 32 | 0.160 |
Why?
|
| Sex Factors | 1 | 2020 | 662 | 0.160 |
Why?
|
| Prenatal Care | 2 | 2015 | 51 | 0.160 |
Why?
|
| Patient-Centered Care | 1 | 2019 | 75 | 0.160 |
Why?
|
| Serologic Tests | 1 | 2018 | 11 | 0.150 |
Why?
|
| Health Personnel | 1 | 2019 | 122 | 0.150 |
Why?
|
| Child | 5 | 2024 | 2425 | 0.150 |
Why?
|
| Prospective Studies | 3 | 2022 | 2277 | 0.150 |
Why?
|
| Malnutrition | 1 | 2016 | 17 | 0.140 |
Why?
|
| Health Services | 1 | 2016 | 38 | 0.140 |
Why?
|
| Anxiety | 3 | 2023 | 188 | 0.140 |
Why?
|
| Government Programs | 1 | 2016 | 9 | 0.140 |
Why?
|
| Resource Allocation | 1 | 2016 | 9 | 0.140 |
Why?
|
| Ethics, Research | 1 | 2016 | 15 | 0.140 |
Why?
|
| Patient Selection | 1 | 2018 | 276 | 0.140 |
Why?
|
| Disease Transmission, Infectious | 1 | 2016 | 17 | 0.130 |
Why?
|
| Preventive Health Services | 1 | 2016 | 44 | 0.130 |
Why?
|
| Pregnancy Rate | 1 | 2015 | 11 | 0.130 |
Why?
|
| Health Services Research | 1 | 2016 | 82 | 0.130 |
Why?
|
| Community Networks | 1 | 2015 | 27 | 0.130 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2015 | 24 | 0.130 |
Why?
|
| Community Health Services | 1 | 2015 | 56 | 0.130 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 284 | 0.120 |
Why?
|
| Retrospective Studies | 1 | 2022 | 3488 | 0.120 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2014 | 2 | 0.120 |
Why?
|
| Antitubercular Agents | 1 | 2014 | 7 | 0.120 |
Why?
|
| Giardiasis | 1 | 2014 | 1 | 0.120 |
Why?
|
| Giardia lamblia | 1 | 2014 | 2 | 0.120 |
Why?
|
| Bacteriological Techniques | 1 | 2014 | 15 | 0.120 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2014 | 24 | 0.120 |
Why?
|
| Dog Diseases | 1 | 2014 | 7 | 0.120 |
Why?
|
| Dogs | 1 | 2014 | 116 | 0.110 |
Why?
|
| Feasibility Studies | 3 | 2019 | 291 | 0.110 |
Why?
|
| Malaria Vaccines | 1 | 2012 | 1 | 0.110 |
Why?
|
| Malaria | 1 | 2012 | 11 | 0.110 |
Why?
|
| Immunization Schedule | 1 | 2012 | 26 | 0.110 |
Why?
|
| Semen | 2 | 2023 | 10 | 0.110 |
Why?
|
| United States | 2 | 2018 | 3925 | 0.100 |
Why?
|
| Mental Health | 2 | 2023 | 115 | 0.100 |
Why?
|
| RNA, Viral | 2 | 2021 | 47 | 0.100 |
Why?
|
| HIV | 2 | 2023 | 24 | 0.090 |
Why?
|
| Students | 2 | 2021 | 171 | 0.090 |
Why?
|
| Methadone | 2 | 2020 | 12 | 0.090 |
Why?
|
| Ethanol | 2 | 2021 | 186 | 0.080 |
Why?
|
| Policy Making | 2 | 2019 | 20 | 0.080 |
Why?
|
| Program Evaluation | 2 | 2020 | 184 | 0.070 |
Why?
|
| Age Factors | 2 | 2020 | 1187 | 0.070 |
Why?
|
| Quality of Life | 2 | 2023 | 924 | 0.070 |
Why?
|
| Infant | 3 | 2015 | 1055 | 0.070 |
Why?
|
| Research Design | 2 | 2020 | 310 | 0.070 |
Why?
|
| Incidence | 2 | 2018 | 1192 | 0.060 |
Why?
|
| Child Welfare | 1 | 2024 | 21 | 0.060 |
Why?
|
| Urban Population | 1 | 2023 | 89 | 0.050 |
Why?
|
| Comorbidity | 1 | 2024 | 566 | 0.050 |
Why?
|
| Anxiety Disorders | 1 | 2023 | 77 | 0.050 |
Why?
|
| Psychometrics | 1 | 2023 | 136 | 0.050 |
Why?
|
| Contraceptive Agents | 1 | 2022 | 4 | 0.050 |
Why?
|
| Risk Factors | 2 | 2023 | 3851 | 0.050 |
Why?
|
| Democratic Republic of the Congo | 1 | 2022 | 2 | 0.050 |
Why?
|
| Pregnant Women | 1 | 2022 | 6 | 0.050 |
Why?
|
| Virus Shedding | 1 | 2021 | 5 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2015 | 665 | 0.050 |
Why?
|
| Schools | 1 | 2021 | 65 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 764 | 0.050 |
Why?
|
| Buprenorphine | 1 | 2020 | 13 | 0.050 |
Why?
|
| Universities | 1 | 2021 | 144 | 0.050 |
Why?
|
| Syphilis Serodiagnosis | 1 | 2020 | 4 | 0.040 |
Why?
|
| Seroepidemiologic Studies | 1 | 2020 | 10 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2020 | 33 | 0.040 |
Why?
|
| Vaccination | 1 | 2021 | 136 | 0.040 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2020 | 34 | 0.040 |
Why?
|
| Naloxone | 1 | 2019 | 26 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2014 | 1259 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2020 | 125 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2020 | 140 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2020 | 215 | 0.040 |
Why?
|
| Self Care | 1 | 2020 | 144 | 0.040 |
Why?
|
| Anal Canal | 1 | 2018 | 20 | 0.040 |
Why?
|
| Angola | 1 | 2018 | 1 | 0.040 |
Why?
|
| Depressive Disorder | 1 | 2018 | 75 | 0.040 |
Why?
|
| Health Policy | 1 | 2019 | 82 | 0.040 |
Why?
|
| Time | 1 | 2018 | 23 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 271 | 0.040 |
Why?
|
| HIV Antibodies | 1 | 2018 | 2 | 0.040 |
Why?
|
| Russia | 1 | 2018 | 5 | 0.040 |
Why?
|
| Directive Counseling | 1 | 2018 | 18 | 0.040 |
Why?
|
| Public Health | 1 | 2019 | 81 | 0.040 |
Why?
|
| Morals | 1 | 2017 | 4 | 0.040 |
Why?
|
| Needle Sharing | 1 | 2017 | 1 | 0.040 |
Why?
|
| Criminals | 1 | 2017 | 2 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 771 | 0.040 |
Why?
|
| Marital Status | 1 | 2017 | 23 | 0.040 |
Why?
|
| Curriculum | 1 | 2019 | 208 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2019 | 349 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 180 | 0.040 |
Why?
|
| Employment | 1 | 2017 | 48 | 0.040 |
Why?
|
| Research | 1 | 2017 | 74 | 0.040 |
Why?
|
| Homosexuality, Male | 1 | 2018 | 83 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2018 | 220 | 0.040 |
Why?
|
| Educational Status | 1 | 2017 | 178 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 756 | 0.030 |
Why?
|
| Patient Rights | 1 | 2016 | 12 | 0.030 |
Why?
|
| Vulnerable Populations | 1 | 2016 | 33 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 420 | 0.030 |
Why?
|
| Post-Exposure Prophylaxis | 1 | 2015 | 4 | 0.030 |
Why?
|
| South Africa | 1 | 2015 | 11 | 0.030 |
Why?
|
| Gender Identity | 1 | 2015 | 22 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2015 | 62 | 0.030 |
Why?
|
| Postpartum Period | 1 | 2015 | 33 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2015 | 43 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2016 | 122 | 0.030 |
Why?
|
| Travel | 1 | 2015 | 15 | 0.030 |
Why?
|
| Motor Vehicles | 1 | 2015 | 25 | 0.030 |
Why?
|
| Tanzania | 1 | 2014 | 12 | 0.030 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2014 | 5 | 0.030 |
Why?
|
| Arizona | 1 | 2014 | 8 | 0.030 |
Why?
|
| Feces | 1 | 2014 | 34 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 135 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 186 | 0.030 |
Why?
|
| Mozambique | 1 | 2012 | 1 | 0.030 |
Why?
|
| Genotype | 1 | 2014 | 727 | 0.030 |
Why?
|
| Decision Making | 1 | 2014 | 194 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 10288 | 0.020 |
Why?
|
| Animals | 1 | 2014 | 7450 | 0.010 |
Why?
|